4.4 Article

Role of non-homologous end joining in V(D)J recombination

期刊

IMMUNOLOGIC RESEARCH
卷 54, 期 1-3, 页码 233-246

出版社

HUMANA PRESS INC
DOI: 10.1007/s12026-012-8329-z

关键词

V(D)J recombination; Non-homologous end joining (NHEJ); Immunodeficiencies; Genomic stability

资金

  1. National Institute of health (NIH) [RO1 AI080755, RO1 AI070532, R01 AI070880]
  2. Irma T. Hirsch/Monique Weill-Caullier Research Award (NIH) [R56AI070532-01A1]
  3. American Cancer Society [RSG-04-191-01 LIB]
  4. Leukemia and Lymphoma Society Scholar Award
  5. NIH [P01 AI061093]

向作者/读者索取更多资源

The pathway of V(D)J recombination was discovered almost three decades ago. Yet it continues to baffle scientists because of its inherent complexity and the multiple layers of regulation that are required to efficiently generate a diverse repertoire of T and B cells. The non-homologous end-joining (NHEJ) DNA repair pathway is an integral part of the V(D)J reaction, and its numerous players perform critical functions in generating this vast diversity, while ensuring genomic stability. In this review, we summarize the efforts of a number of laboratories including ours in providing the mechanisms of V(D)J regulation with a focus on the NHEJ pathway. This involves discovering new players, unraveling unknown roles for known components, and understanding how deregulation of these pathways contributes to generation of primary immunodeficiencies. A long-standing interest of our laboratory has been to elucidate various mechanisms that control RAG activity. Our recent work has focused on understanding the multiple protein-protein interactions and protein-DNA interactions during V(D)J recombination, which allow efficient and regulated generation of the antigen receptors. Exploring how deregulation of this process contributes to immunodeficiencies also continues to be an important area of research for our group.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据